Trump Administration Accelerates Psychedelic Research for PTSD

Bitcoin

This move dovetails with the broader trend of de‑regulation in high‑risk innovation spaces (e.g., crypto, AI, gene‑editing). As Washington shows willingness to accelerate research pipelines, investors may extrapolate that similar regulatory momentum could eventually benefit crypto projects that position themselves as “science‑first” or health‑oriented. The policy also reinforces the narrative that the US is a global hub for frontier‑tech financing.

A US executive order was issued to streamline investigations of psychedelic drugs, including ibogaine.